351 related articles for article (PubMed ID: 37046762)
21. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy.
Yang Y; An Y; Dong Y; Chu Q; Wei J; Wang B; Cao H
EBioMedicine; 2024 Feb; 100():104967. PubMed ID: 38241975
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiome and cancer immunotherapy.
Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
[TBL] [Abstract][Full Text] [Related]
23. The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Oh B; Boyle F; Pavlakis N; Clarke S; Eade T; Hruby G; Lamoury G; Carroll S; Morgia M; Kneebone A; Stevens M; Liu W; Corless B; Molloy M; Kong B; Libermann T; Rosenthal D; Back M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638308
[No Abstract] [Full Text] [Related]
24. [Association between Immunotherapy with Immune Checkpoint Inhibitors(Anti-PD-1 Antibodies)and Intestinal Microbiota].
Ozaki Y; Suzuki Y; Nishiyama K; Suzutani T; Suzuki H
Gan To Kagaku Ryoho; 2021 Sep; 48(9):1096-1099. PubMed ID: 34521783
[TBL] [Abstract][Full Text] [Related]
25. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
[TBL] [Abstract][Full Text] [Related]
26. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
27. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer.
Kang YB; Cai Y
World J Gastroenterol; 2021 Aug; 27(32):5362-5375. PubMed ID: 34539138
[TBL] [Abstract][Full Text] [Related]
28. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
Roberto M; Carconi C; Cerreti M; Schipilliti FM; Botticelli A; Mazzuca F; Marchetti P
Front Immunol; 2021; 12():704942. PubMed ID: 34489956
[TBL] [Abstract][Full Text] [Related]
29. The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review.
Araji G; Maamari J; Ahmad FA; Zareef R; Chaftari P; Yeung SJ
J Immunother Precis Oncol; 2022 Feb; 5(1):13-25. PubMed ID: 35663831
[TBL] [Abstract][Full Text] [Related]
30. The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy.
Liu X; Cheng Y; Zang D; Zhang M; Li X; Liu D; Gao B; Zhou H; Sun J; Han X; Lin M; Chen J
Front Oncol; 2021; 11():720842. PubMed ID: 34490119
[TBL] [Abstract][Full Text] [Related]
31. Gut Microbiota in Cancer Immune Response and Immunotherapy.
Zhou CB; Zhou YL; Fang JY
Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review.
Hwang SW; Kim MK; Kweon MN
Intest Res; 2023 Oct; 21(4):433-442. PubMed ID: 37640378
[TBL] [Abstract][Full Text] [Related]
33. The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer.
Katayama Y; Yamada T; Shimamoto T; Iwasaku M; Kaneko Y; Uchino J; Takayama K
Transl Lung Cancer Res; 2019 Dec; 8(6):847-853. PubMed ID: 32010563
[TBL] [Abstract][Full Text] [Related]
34. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
35. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
36. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis.
Zhou G; Zhang N; Meng K; Pan F
Front Immunol; 2022; 13():1001623. PubMed ID: 36389768
[TBL] [Abstract][Full Text] [Related]
37. Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition.
Guardamagna M; Berciano-Guerrero MA; Villaescusa-González B; Perez-Ruiz E; Oliver J; Lavado-Valenzuela R; Rueda-Dominguez A; Barragán I; Queipo-Ortuño MI
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233289
[TBL] [Abstract][Full Text] [Related]
38. Clinical Applications of the Gut Microbiome in Genitourinary Cancers.
Nguyen CB; Vaishampayan UN
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e100041. PubMed ID: 38788173
[TBL] [Abstract][Full Text] [Related]
39. Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.
Shoji F; Miura N; Tagawa T; Tsukamoto S; Okamoto T; Yamazaki K; Hamatake M; Takeo S
Thorac Cancer; 2022 Oct; 13(19):2829-2833. PubMed ID: 36063818
[TBL] [Abstract][Full Text] [Related]
40. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications.
Lee KA; Shaw HM; Bataille V; Nathan P; Spector TD
Eur J Cancer; 2020 Oct; 138():149-155. PubMed ID: 32889369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
